Abbvie Inc Cdr Stock Chance of Future Stock Price Finishing Under 23.93

ABBV Stock   26.56  0.46  1.70%   
AbbVie's future price is the expected price of AbbVie instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of AbbVie Inc CDR performance during a given time horizon utilizing its historical volatility. Check out AbbVie Backtesting, AbbVie Valuation, AbbVie Correlation, AbbVie Hype Analysis, AbbVie Volatility, AbbVie History as well as AbbVie Performance.
  
Please specify AbbVie's target price for which you would like AbbVie odds to be computed.

AbbVie Target Price Odds to finish below 23.93

The tendency of AbbVie Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to  23.93  or more in 90 days
 26.56 90 days 23.93 
near 1
Based on a normal probability distribution, the odds of AbbVie to drop to  23.93  or more in 90 days from now is near 1 (This AbbVie Inc CDR probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 90 days) . Probability of AbbVie Inc CDR price to stay between  23.93  and its current price of 26.56 at the end of the 90-day period is about 25.54 .
Assuming the 90 days trading horizon AbbVie Inc CDR has a beta of -0.13. This suggests as returns on the benchmark increase, returns on holding AbbVie are expected to decrease at a much lower rate. During a bear market, however, AbbVie Inc CDR is likely to outperform the market. Additionally AbbVie Inc CDR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   AbbVie Price Density   
       Price  

Predictive Modules for AbbVie

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AbbVie Inc CDR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
24.4526.5628.67
Details
Intrinsic
Valuation
LowRealHigh
20.2822.3929.22
Details
Naive
Forecast
LowNextHigh
26.7428.8530.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.8425.7627.69
Details

AbbVie Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. AbbVie is not an exception. The market had few large corrections towards the AbbVie's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AbbVie Inc CDR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AbbVie within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.06
β
Beta against Dow Jones-0.13
σ
Overall volatility
1.41
Ir
Information ratio -0.1

AbbVie Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AbbVie for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AbbVie Inc CDR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AbbVie Inc CDR generated a negative expected return over the last 90 days
Latest headline from news.google.com: I dont think the games even started on this next cycle - QC Copper Golds Stephen Stewart - Kitco NEWS

AbbVie Technical Analysis

AbbVie's future price can be derived by breaking down and analyzing its technical indicators over time. AbbVie Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AbbVie Inc CDR. In general, you should focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environments and drivers.

AbbVie Predictive Forecast Models

AbbVie's time-series forecasting models is one of many AbbVie's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AbbVie's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about AbbVie Inc CDR

Checking the ongoing alerts about AbbVie for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AbbVie Inc CDR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AbbVie Inc CDR generated a negative expected return over the last 90 days
Latest headline from news.google.com: I dont think the games even started on this next cycle - QC Copper Golds Stephen Stewart - Kitco NEWS

Other Information on Investing in AbbVie Stock

AbbVie financial ratios help investors to determine whether AbbVie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbbVie with respect to the benefits of owning AbbVie security.